NSCLC - Non Small Cell Lung Cancer Now Closed
Checkmate 816 / CA209-816 - Hosted By elie
Save
Bookmark
Print
| Sponsor Name | |
| Tumor Site | NSCLC - Non Small Cell Lung Cancer |
| Disease Stage | Stage I, Stage II, Stage III |
| Clinical Status | Neo-Adjuvant, Operable |
| Phase | Phase III |
| Intervention / Treatment | Nivolumab and Ipilimumab + Chemotherapy versus Chemotherapy Alone |
| Research Site | Montreal, QC, McGill University Health Center, Montreal University Hospital Center |
| Investigator | Dre Jonathan Spicer |
| Telephone Number | +1 (514) 934-4411 |
| Study Start Date | December 20, 2016 |
| Study End Date | November 6, 2018 |
| Trial Status | Recruitment |
